Chronic inflammation in tumor stroma is an independent predictor of prolonged survival in epithelioid malignant pleural mesothelioma patients

Cancer Immunology, Immunotherapy

Volumn 60, Issue 12, 2011, Pages 1721-1728

  Suzuki, Kei ^a   Kadota, Kyuichi ^a   Sima, Camelia S ^a   Sadelain, Michel ^a   Rusch, Valerie W ^a   Travis, William D ^a   Adusumilli, Prasad S ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Epithelioid mesothelioma; Immune response; Prognosis; Tumor stroma

Indexed keywords

EOSIN; HEMATOXYLIN;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CELL INFILTRATION; CHRONIC INFLAMMATION; CLINICAL ASSESSMENT; CONNECTIVE TISSUE TUMOR; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MALIGNANT MESOTHELIOMA; OVERALL SURVIVAL; PLEURA MESOTHELIOMA; PREDICTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; STROMA; TUMOR LOCALIZATION;

ADULT; AGED; AGED, 80 AND OVER; CHRONIC DISEASE; FEMALE; HUMANS; INFLAMMATION; KAPLAN-MEIER ESTIMATE; MALE; MESOTHELIOMA; MIDDLE AGED; NEOPLASM STAGING; PLEURAL NEOPLASMS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; TUMOR MICROENVIRONMENT;

EID: 82355182060     PISSN: 03407004     EISSN: 14320851     Source Type: Journal    
DOI: 10.1007/s00262-011-1073-8     Document Type: Article

References (28)

1. F Pages A Berger M Camus F Sanchez-Cabo A Costes R Molidor B Mlecnik A Kirilovsky M Nilsson D Damotte T Meatchi P Bruneval P-H Cugnenc Z Trajanoski W-H Fridman J Galon 2005 Effector memory T cells, early metastasis, and survival in colorectal cancer N Engl J Med 353 2654 2666 16371631 10.1056/NEJMoa051424 1:CAS:528:DC%2BD2MXhtlarsrrE (Pubitemid 41817714)
2. L Zhang JR Conejo-Garcia D Katsaros PA Gimotty M Massobrio G Regnani A Makrigiannakis H Gray K Schlienger MN Liebman SC Rubin G Coukos 2003 Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer N Engl J Med 348 203 213 12529460 10.1056/NEJMoa020177 1:CAS:528: DC%2BD3sXksVehug%3D%3D (Pubitemid 36077915)
3. KI Al-Shibli T Donnem S Al-Saad M Persson RM Bremnes L-T Busund 2008 Prognostic effect of epithelial and stromal lymphocyte infiltration in non-small cell lung cancer Clin Cancer Res 14 5220 5227 18698040 10.1158/1078-0432.CCR- 08-0133 1:CAS:528:DC%2BD1cXpslKgu7Y%3D
4. J Galon A Costes F Sanchez-Cabo A Kirilovsky B Mlecnik C Lagorce-Pages M Tosolini M Camus A Berger P Wind F Zinzindohoue P Bruneval P-H Cugnenc Z Trajanoski W-H Fridman F Pages 2006 Type, density, and location of immune cells within human colorectal tumors predict clinical outcome Science 313 1960 1964 17008531 10.1126/science.1129139 1:CAS:528:DC%2BD28XhtVSnsrnK (Pubitemid 44498003)
5. BWS Robinson AW Musk RA Lake 2005 Malignant mesothelioma Lancet 366 397 408 16054941 10.1016/S0140-6736(05)67025-0 1:CAS:528:DC%2BD2MXmvVWmtr4%3D (Pubitemid 41073959)
6. DJ Sugarbaker RM Flores MT Jaklitsch WG Richards GM Strauss JM Corson MM DeCamp Jr SJ Swanson R Bueno JM Lukanich EH Baldini SJ Mentzer 1999 Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results of 183 patients J Thorac Cardiovasc Surg 117 54 65 9869758 10.1016/S0022-5223(99)70469-1 1:STN:280:DyaK1M7gt1Ghug%3D%3D (Pubitemid 29022249)
7. RA Leigh I Webster 1982 Lymphocytic infiltration of pleural mesothelioma and its significance for survival S Afr Med J 61 1007 1009 7089768 1:STN:280:DyaL383isVeisw%3D%3D (Pubitemid 12045175)
8. M Anraku KS Cunningham Z Yun M-S Tsao L Zhang S Keshavjee MR Johnston M de Perrot 2008 Impact of tumor-infiltrating T cells on survival in patients with malignant pleural mesothelioma J Thorac Cardiovasc Surg 135 823 829 18374762 10.1016/j.jtcvs.2007.10.026 (Pubitemid 351417931)
9. Yamada N, Oizumi S, Kikuchi E, Shinagawa N, Konishi-Sakakibara J, Ishimine A, Aoe K, Gemba K, Kishimoto T, Torigoe T, Nishimura M (2010) CD8 + tumor-infiltrating lymphocytes predict favorable prognosis in malignant pleural mesothelioma after resection. Cancer Immunol Immunother 59(10):1543-1549
10. G Alì L Boldrini M Lucchi A Mussi V Corsi G Fontanini 2009 Tryptase mast cells in malignant pleural mesothelioma as an independent favorable prognostic factor J Thorac Oncol 4 348 354 10.1097/JTO. 0b013e3181989ddb 19155997 10.1097/JTO.0b013e3181989ddb
11. HS Mudhar WAH Wallace 2002 No relationship between tumour infiltrating lymphocytes and overall survival is seen in malignant mesothelioma of the pleura Eur J Surg Oncol (EJSO) 28 564 565 10.1053/ejso.2002.1294 1:STN:280: DC%2BD38vlvFamuw%3D%3D (Pubitemid 35446788)
12. SCH Kao N Pavlakis R Harvie JL Vardy MJ Boyer N van Zandwijk SJ Clarke 2010 High blood neutrophil-to-lymphocyte ratio is an indicator of poor prognosis in malignant mesothelioma patients undergoing systemic therapy Clin Cancer Res 16 5805 5813 20956618 10.1158/1078-0432.CCR-10-2245 1:CAS:528:DC%2BC3cXhsFamtLvN
13. Travis W, Colby T, Corrin B, Shimosato Y, Brambilla E (1999) World health organization international histological classification of tumours: histological subtyping of lung and pleural tumours, 3rd edn. Springer, Berlin
14. Travis W, Brambilla E, Muller-Hermelink H, Harris C (2004) Pathology and genetics. Tumours of the lung, pleura, thymus, and heart. IARC Press, Lyon
15. Greene F, Page D, Fleming I, Fritz A, Balch C, Haller D, Morrow M (2002) AJCC cancer staging manual. Springer, New York
16. K Hiraoka M Miyamoto Y Cho M Suzuoki T Oshikiri Y Nakakubo T Itoh T Ohbuchi S Kondo H Katoh 2006 Concurrent infiltration by CD8 + T cells and CD4 + T cells is a favourable prognostic factor in non-small-cell lung carcinoma Br J Cancer 94 275 280 16421594 10.1038/sj.bjc.6602934 1:CAS:528: DC%2BD28XmvVynsQ%3D%3D (Pubitemid 43151547)
17. TD Tlsty LM Coussens 2006 Tumor stroma and regulation of cancer development Annu Rev Pathol Mech Dis 1 119 150 10.1146/annurev.pathol.1.110304. 100224 1:CAS:528:DC%2BD28XktVOitb0%3D
18. T Blankenstein 2005 The role of tumor stroma in the interaction between tumor and immune system Curr Opin Immunol 17 180 186 15766679 10.1016/j.coi.2005.01.008 1:CAS:528:DC%2BD2MXit1ChtL0%3D (Pubitemid 40343106)
19. SMA Mahmoud EC Paish DG Powe RD Macmillan MJ Grainge AHS Lee IO Ellis AR Green 2011 Tumor-infiltrating CD8 + lymphocytes predict clinical outcome in breast cancer J Clinical Oncol 29 1949 1955 10.1200/JCO.2010.30.5037
20. JPJJ Hegmans A Hemmes H Hammad L Boon HC Hoogsteden BN Lambrecht 2006 Mesothelioma environment comprises cytokines and T-regulatory cells that suppress immune responses Eur Respir J 27 1086 1095 16540497 10.1183/09031936.06.00135305 1:CAS:528:DC%2BD28XlvF2hsb0%3D (Pubitemid 44914290)
21. ZG Fridlender G Buchlis V Kapoor G Cheng J Sun S Singhal MC Crisanti L-CS Wang D Heitjan LA Snyder SM Albelda 2010 CCL2 blockade augments cancer immunotherapy Cancer Res 70 109 118 20028856 10.1158/0008-5472.CAN-09-2326 1:CAS:528:DC%2BC3cXkvFOr
22. KE de Visser A Eichten LM Coussens 2006 Paradoxical roles of the immune system during cancer development Nat Rev Cancer 6 24 37 16397525 10.1038/nrc1782 (Pubitemid 43053650)
23. Y Shigematsu T Hanagiri K Kuroda T Baba M Mizukami Y Ichiki M Yasuda M Takenoyama K Sugio K Yasumoto 2009 Malignant mesothelioma-associated antigens recognized by tumor-infiltrating B cells and the clinical significance of the antibody titers Cancer Sci 100 1326 1334 19432887 10.1111/j.1349-7006.2009. 01181.x 1:CAS:528:DC%2BD1MXosl2kur0%3D
24. J-D Bouaziz K Yanaba TF Tedder 2008 Regulatory B cells as inhibitors of immune responses and inflammation Immunol Rev 224 201 214 18759928 10.1111/j.1600-065X.2008.00661.x 1:CAS:528:DC%2BD1cXhtF2qurbM
25. M Johansson DG DeNardo LM Coussens 2008 Polarized immune responses differentially regulate cancer development Immunol Rev 222 145 154 18363999 10.1111/j.1600-065X.2008.00600.x 1:CAS:528:DC%2BD1cXlsFejtrY%3D (Pubitemid 351430362)
26. X An P-R Ding Y-H Li F-H Wang Y-X Shi Z-Q Wang Y-J He R-H Xu W-Q Jiang 2010 Elevated neutrophil to lymphocyte ratio predicts survival in advanced pancreatic cancer Biomarkers 15 516 522 20602543 10.3109/1354750X.2010.491557 1:CAS:528:DC%2BC3cXhtVCmsr3N
27. SR Walsh EJ Cook F Goulder TA Justin NJ Keeling 2005 Neutrophil- lymphocyte ratio as a prognostic factor in colorectal cancer J Surg Oncol 91 181 184 16118772 10.1002/jso.20329 1:STN:280:DC%2BD2MvlvFCjtA%3D%3D (Pubitemid 41254421)
28. K Sarraf E Belcher E Raevsky A Nicholson P Goldstraw E Lim 2009 Neutrophil/lymphocyte ratio and its association with survival after complete resection in non-small cell lung cancer J Thorac Cardiovasc Surg 137 425 428 19185164 10.1016/j.jtcvs.2008.05.046